AXIOS | The COVID-19 pandemic is exposing the dire state of the antibacterial pipeline, and the urgent need for investment to be prepared for more antibiotic resistant infections to emerge. The US Government Accountability Office last week publicly released a report with eight recommendations for the federal government on how to better determine and address the problem. The conclusion? Having a full and effective arsenal of antibiotics, antimicrobials and antifungals is an important component of being prepared for the next pandemic.